View of CLINICAL HETEROGENEITY AND PROGNOSTIC STRATIFICATION OF POST-COVID RHEUMATIC DISEASES: FROM MOLECULAR BIOMARKERS TO JOINT SYNDROME PHENOTYPES

Return to Issue Details CLINICAL HETEROGENEITY AND PROGNOSTIC STRATIFICATION OF POST-COVID RHEUMATIC DISEASES: FROM MOLECULAR BIOMARKERS TO JOINT SYNDROME PHENOTYPES Download Download PDF